↓ Skip to main content

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

Overview of attention for article published in New England Journal of Medicine, November 1998
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Readers on

mendeley
346 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Article details
Title
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
Published in
New England Journal of Medicine, November 1998
DOI 10.1056/nejm199811193392101
Pubmed ID
Authors

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 346 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Spain 4 1%
United Kingdom 2 <1%
United States 1 <1%
Pakistan 1 <1%
Sri Lanka 1 <1%
Italy 1 <1%
China 1 <1%
Argentina 1 <1%
Unknown 334 97%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Student > Ph. D. Student 62 18%
Researcher 43 12%
Student > Bachelor 40 12%
Student > Master 35 10%
Student > Doctoral Student 28 8%
Other 72 21%
Unknown 66 19%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 111 32%
Agricultural and Biological Sciences 60 17%
Biochemistry, Genetics and Molecular Biology 33 10%
Immunology and Microbiology 20 6%
Pharmacology, Toxicology and Pharmaceutical Science 18 5%
Other 31 9%
Unknown 73 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 74. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 July 2024.
All research outputs
#736,575
of 34,457,357 outputs
Outputs from New England Journal of Medicine
#8,546
of 38,407 outputs
Outputs of similar age
#570
of 154,691 outputs
Outputs of similar age from New England Journal of Medicine
#7
of 141 outputs
Altmetric has tracked 34,457,357 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,407 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 154,691 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 141 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.